Frank Diehl
Frank Diehl
Sysmex Inostics
E-mail megerősítve itt: sysmex-inostics.com
Cím
Hivatkozott rá
Hivatkozott rá
Év
Circulating mutant DNA to assess tumor dynamics
F Diehl, K Schmidt, MA Choti, K Romans, S Goodman, M Li, K Thornton, ...
Nature medicine 14 (9), 985-990, 2008
20882008
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl, M Li, D Dressman, Y He, D Shen, S Szabo, LA Diaz, ...
Proceedings of the National Academy of Sciences 102 (45), 16368-16373, 2005
11682005
Comparative lesion sequencing provides insights into tumor evolution
S Jones, W Chen, G Parmigiani, F Diehl, N Beerenwinkel, T Antal, ...
Proceedings of the National Academy of Sciences 105 (11), 4283-4288, 2008
8342008
Development of personalized tumor biomarkers using massively parallel sequencing
RJ Leary, I Kinde, F Diehl, K Schmidt, C Clouser, C Duncan, A Antipova, ...
Science translational medicine 2 (20), 20ra14-20ra14, 2010
5682010
BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions
F Diehl, M Li, Y He, KW Kinzler, B Vogelstein, D Dressman
Nature methods 3 (7), 551-559, 2006
4812006
Antibody microarrays: an evaluation of production parameters
W Kusnezow, A Jacob, A Walijew, F Diehl, JD Hoheisel
Proteomics 3 (3), 254-264, 2003
3832003
Sensitive digital quantification of DNA methylation in clinical samples
M Li, W Chen, N Papadopoulos, SN Goodman, NC Bjerregaard, ...
Nature biotechnology 27 (9), 858, 2009
3342009
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood
MJ Higgins, D Jelovac, E Barnathan, B Blair, S Slater, P Powers, J Zorzi, ...
Clinical cancer research 18 (12), 3462-3469, 2012
3132012
BEAMing up for detection and quantification of rare sequence variants
M Li, F Diehl, D Dressman, B Vogelstein, KW Kinzler
Nature methods 3 (2), 95-97, 2006
3002006
Manufacturing DNA microarrays of high spot homogeneity and reduced background signal
F Diehl, S Grahlmann, M Beier, JD Hoheisel
Nucleic acids research 29 (7), e38-e38, 2001
2992001
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle
T Mirzadegan, F Diehl, B Ebi, S Bhakta, I Polsky, D McCarley, M Mulkins, ...
Journal of Biological Chemistry 275 (33), 25562-25571, 2000
2972000
Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients
F Diehl, K Schmidt, KH Durkee, KJ Moore, SN Goodman, AP Shuber, ...
Gastroenterology 135 (2), 489-498. e7, 2008
2732008
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
MP Morelli, MJ Overman, A Dasari, SMA Kazmi, T Mazard, E Vilar, ...
Annals of Oncology 26 (4), 731-736, 2015
1992015
Serial assessment of human tumor burdens in mice by the analysis of circulating DNA
C Rago, DL Huso, F Diehl, B Karim, G Liu, N Papadopoulos, Y Samuels, ...
Cancer research 67 (19), 9364-9370, 2007
1532007
Performance of Streck cfDNA blood collection tubes for liquid biopsy testing
I Medina Diaz, A Nocon, DH Mehnert, J Fredebohm, F Diehl, F Holtrup
PloS one 11 (11), e0166354, 2016
1362016
Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2
K Jarnagin, D Grunberger, M Mulkins, B Wong, S Hemmerich, C Paavola, ...
Biochemistry 38 (49), 16167-16177, 1999
1331999
Digital quantification of mutant DNA in cancer patients
F Diehl, LA Diaz Jr
Current opinion in oncology 19 (1), 36-42, 2007
1102007
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
F Janku, P Angenendt, AM Tsimberidou, S Fu, A Naing, GS Falchook, ...
Oncotarget 6 (14), 12809, 2015
902015
Analysis of stage-specific gene expression in the bloodstream and the procyclic form of Trypanosoma brucei using a genomic DNA-microarray
S Diehl, F Diehl, NM El-Sayed, C Clayton, JD Hoheisel
Molecular and biochemical parasitology 123 (2), 115-123, 2002
862002
Combined targeting of AKT and mTOR using MK‐2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
F Ewald, N Grabinski, A Grottke, S Windhorst, D Nörz, L Carstensen, ...
International journal of cancer 133 (9), 2065-2076, 2013
732013
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20